INR 770.0
(0.82%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.28 Billion INR | 44.41% |
2022 | 1.58 Billion INR | 13.67% |
2021 | 1.39 Billion INR | 62.73% |
2020 | 854.75 Million INR | -3.39% |
2019 | 884.78 Million INR | -1.26% |
2018 | 896.06 Million INR | -2.38% |
2017 | 917.94 Million INR | 70.61% |
2016 | 538.04 Million INR | 29.49% |
2015 | 415.5 Million INR | 8.29% |
2014 | 383.67 Million INR | 15.65% |
2013 | 331.75 Million INR | 12.9% |
2012 | 293.85 Million INR | 3.18% |
2011 | 284.79 Million INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q2 | 1.84 Billion INR | 0.0% |
2023 FY | 2.28 Billion INR | 44.41% |
2023 Q4 | 2.28 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2022 Q4 | 1.58 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 1.58 Billion INR | 13.67% |
2022 Q2 | 1.57 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2021 FY | 1.39 Billion INR | 62.73% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 1.21 Billion INR | 0.0% |
2021 Q4 | 1.39 Billion INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 FY | 854.75 Million INR | -3.39% |
2020 Q4 | 854.75 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 982.26 Million INR | 0.0% |
2019 Q4 | 884.78 Million INR | 0.0% |
2019 FY | 884.78 Million INR | -1.26% |
2019 Q3 | - INR | -100.0% |
2019 Q2 | 923.7 Million INR | 0.0% |
2018 FY | 896.06 Million INR | -2.38% |
2018 Q4 | 896.06 Million INR | 0.0% |
2018 Q2 | 930.05 Million INR | 0.0% |
2017 Q2 | 849.26 Million INR | 0.0% |
2017 Q4 | 917.94 Million INR | 0.0% |
2017 FY | 917.94 Million INR | 70.61% |
2016 Q1 | 467.07 Million INR | 0.0% |
2016 FY | 538.04 Million INR | 29.49% |
2016 Q4 | 538.04 Million INR | 7.87% |
2016 Q3 | 498.79 Million INR | 0.0% |
2015 FY | 415.5 Million INR | 8.29% |
2014 FY | 383.67 Million INR | 15.65% |
2013 FY | 331.75 Million INR | 12.9% |
2012 FY | 293.85 Million INR | 3.18% |
2011 FY | 284.79 Million INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Biocon Limited | 560.7 Billion INR | 99.593% |
Blue Jet Healthcare Limited | 10.58 Billion INR | 78.436% |
Concord Biotech Limited | 17 Billion INR | 86.575% |
Dishman Carbogen Amcis Limited | 95.81 Billion INR | 97.617% |
Jubilant Ingrevia Limited | 47.31 Billion INR | 95.175% |
Lyka Labs Limited | 1.56 Billion INR | -45.688% |
Panacea Biotec Limited | 12.4 Billion INR | 81.597% |
Piramal Pharma Limited | 153.11 Billion INR | 98.509% |
SMS Lifesciences India Limited | 3.9 Billion INR | 41.532% |
Supriya Lifescience Limited | 9.21 Billion INR | 75.215% |
Syngene International Limited | 61.51 Billion INR | 96.288% |
TAKE Solutions Limited | 881.05 Million INR | -159.155% |